Literature DB >> 19372236

Endogenous betaglycan is essential for high-potency inhibin antagonism in gonadotropes.

Ezra Wiater1, Kathy A Lewis, Cynthia Donaldson, Joan Vaughan, Louise Bilezikjian, Wylie Vale.   

Abstract

Inhibins are endocrine hormones that regulate gametogenesis and reproduction through a negative feedback loop with FSH. Inhibin action involves antagonism of signaling by activin or other TGFbeta family ligands. In transfection assays, antagonism by inhibin can be potentiated by betaglycan, a coreceptor for selected TGFbeta family ligands. We tested whether betaglycan is an obligate inhibin coreceptor through disruption of betaglycan function by RNA interference-mediated knockdown and immunoneutralization. Betaglycan knockdown and anti-betaglycan IgG each independently prevented inhibin-A binding to betaglycan and reversed functional effects of transfected betaglycan. Neither betaglycan immunoneutralization nor knockdown affected activin responsiveness in cell lines or in rat anterior pituitary cultures. Betaglycan knockdown decreased the potency of inhibin antagonism of activin-induced FSH secretion in primary gonadotropes. Similarly, anti-betaglycan IgG decreased the potency of inhibin antagonism in primary gonadotropes in a dose-dependent manner, with a reduction in the sensitivity to inhibin-A of greater than 1000-fold. These data establish that betaglycan is an endogenous inhibin coreceptor required for high-sensitivity inhibin antagonism of activin signaling in rat anterior pituitary gonadotropes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372236      PMCID: PMC2703594          DOI: 10.1210/me.2009-0021

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  43 in total

1.  Expression cloning of an activin receptor, a predicted transmembrane serine kinase.

Authors:  L S Mathews; W W Vale
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

2.  Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system.

Authors:  F López-Casillas; S Cheifetz; J Doody; J L Andres; W S Lane; J Massagué
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

3.  Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells.

Authors:  L M Bilezikjian; A L Blount; C A Campen; C Gonzalez-Manchon; W Vale
Journal:  Mol Endocrinol       Date:  1991-10

Review 4.  Inhibin, activin and the female reproductive axis.

Authors:  T K Woodruff; J P Mather
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

5.  Assay of corticotropin releasing factor.

Authors:  W Vale; J Vaughan; G Yamamoto; T Bruhn; C Douglas; D Dalton; C Rivier; J Rivier
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Alpha 2-macroglobulin is a binding protein of inhibin and activin.

Authors:  J M Vaughan; W W Vale
Journal:  Endocrinology       Date:  1993-05       Impact factor: 4.736

7.  Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.

Authors:  T R Kumar; Y Wang; M M Matzuk
Journal:  Endocrinology       Date:  1996-10       Impact factor: 4.736

8.  Betaglycan presents ligand to the TGF beta signaling receptor.

Authors:  F López-Casillas; J L Wrana; J Massagué
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

9.  Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.

Authors:  J Xu; K McKeehan; K Matsuzaki; W L McKeehan
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

10.  Purification and partial characterization of inhibin from porcine follicular fluid.

Authors:  J Rivier; J Spiess; R McClintock; J Vaughan; W Vale
Journal:  Biochem Biophys Res Commun       Date:  1985-11-27       Impact factor: 3.575

View more
  14 in total

Review 1.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

Review 2.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

3.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

Review 4.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Authors:  Louise M Bilezikjian; Nicholas J Justice; Alissa N Blackler; Ezra Wiater; Wylie W Vale
Journal:  Mol Cell Endocrinol       Date:  2012-02-04       Impact factor: 4.102

5.  Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage.

Authors:  Christopher P Morgan; Tracy L Bale
Journal:  J Neurosci       Date:  2011-08-17       Impact factor: 6.167

6.  Structure of betaglycan zona pellucida (ZP)-C domain provides insights into ZP-mediated protein polymerization and TGF-beta binding.

Authors:  S Jack Lin; Yaoxiong Hu; Jie Zhu; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

7.  Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Yao Wang; Han L Tan; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2013-01-15

8.  Phylogenomic analyses reveal the evolutionary origin of the inhibin alpha-subunit, a unique TGFbeta superfamily antagonist.

Authors:  Jie Zhu; Edward L Braun; Satomi Kohno; Monica Antenos; Eugene Y Xu; Robert W Cook; S Jack Lin; Brandon C Moore; Louis J Guillette; Theodore S Jardetzky; Teresa K Woodruff
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

Review 9.  More than an accessory: implications of type III transforming growth factor-beta receptor loss in prostate cancer.

Authors:  Seun Ajiboye; Tristan M Sissung; Nima Sharifi; William D Figg
Journal:  BJU Int       Date:  2010-01-08       Impact factor: 5.588

10.  Betaglycan (TGFBR3) Functions as an Inhibin A, but Not Inhibin B, Coreceptor in Pituitary Gonadotrope Cells in Mice.

Authors:  Yining Li; Jérôme Fortin; Luisina Ongaro; Xiang Zhou; Ulrich Boehm; Alan Schneyer; Daniel J Bernard; Herbert Y Lin
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.